1049 |
How to Do Endovascular Interventions Below the Knee Interventions: What You Need to Know Before You Start |
Issam D. Moussa |
May. 12. 11 |
1048 |
Evolving Horizon: Drug-coated Balloons or Drug-coated Stents in SFA Diseases? |
Mark W. Burket |
May. 12. 11 |
1047 |
Current Treatment of Femoropopiteal In-stent Restenosis |
John R. Laird |
May. 12. 11 |
1046 |
Crossing the Long SFA CTO: Techniques and Variables You Need to Know |
Shigeru Saito |
May. 12. 11 |
1045 |
Antegrade vs. Retrograde Recanalization of Very Long CTO of SFA |
Andrej Schmidt |
May. 12. 11 |
1044 |
BIOFREEDOM: Polymer-Free Biolimus A9-Eluting Stents and Paclitaxel-Eluting Stents |
Eberhard Grube |
May. 12. 11 |
1043 |
BIOMATRIX: Learned from the Three-Year LEADERS Trial |
Patrick W. Serruys |
May. 12. 11 |
1042 |
The BIOTRONIK Bioabsorbable Magnesium Scaffold DREAMS |
Ron Waksman |
May. 12. 11 |
1041 |
DES Technologies: Evolution of BioMime |
Wojciech Wojakowski |
May. 12. 11 |
1040 |
The Latest Technique in Endovascular CTO |
Hiroyoshi Yokoi |
May. 12. 11 |